Caveolin-deficient mice: insights into caveolar function and human disease

被引:185
作者
Razani, B
Lisanti, MP
机构
[1] Albert Einstein Coll Med, Albert Einstein Comprehens Canc Ctr, Dept Mol Pharmacol, Bronx, NY 10461 USA
[2] Albert Einstein Coll Med, Albert Einstein Comprehens Canc Ctr, Div Hormone Dependent Tumor Biol, Bronx, NY 10461 USA
关键词
D O I
10.1172/JCI14611
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:1553 / 1561
页数:9
相关论文
共 45 条
[1]   Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease [J].
Betz, RC ;
Schoser, BGH ;
Kasper, D ;
Ricker, K ;
Ramírez, A ;
Stein, V ;
Torbergsen, T ;
Lee, YA ;
Nöthen, MM ;
Wienker, TF ;
Malin, JP ;
Propping, P ;
Reis, A ;
Mortier, W ;
Jentsch, TJ ;
Vorgerd, M ;
Kubisch, C .
NATURE GENETICS, 2001, 28 (03) :218-219
[2]   In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation [J].
Bucci, M ;
Gratton, JP ;
Rudic, RD ;
Acevedo, L ;
Roviezzo, F ;
Cirino, G ;
Sessa, WC .
NATURE MEDICINE, 2000, 6 (12) :1362-1367
[3]   Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia [J].
Carbone, I ;
Bruno, C ;
Sotgia, F ;
Bado, M ;
Broda, P ;
Masetti, E ;
Panella, A ;
Zara, F ;
Bricarelli, FD ;
Cordone, G ;
Lisanti, MP ;
Minetti, C .
NEUROLOGY, 2000, 54 (06) :1373-1376
[4]   Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice [J].
Drab, M ;
Verkade, P ;
Elger, M ;
Kasper, M ;
Lohn, M ;
Lauterbach, B ;
Menne, J ;
Lindschau, C ;
Mende, F ;
Luft, FC ;
Schedl, A ;
Haller, H ;
Kurzchalia, TV .
SCIENCE, 2001, 293 (5539) :2449-2452
[5]   Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth [J].
Engelman, JA ;
Wykoff, CC ;
Yasuhara, S ;
Song, KS ;
Okamoto, T ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (26) :16374-16381
[6]   Cholesterol and caveolae: structural and functional relationships [J].
Fielding, CJ ;
Fielding, PE .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2000, 1529 (1-3) :210-222
[7]   Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation -: Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutants and rescues wild-type caveolin-3 [J].
Galbiati, F ;
Volonté, D ;
Minetti, C ;
Bregman, DB ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (48) :37702-37711
[8]   Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts -: Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation [J].
Galbiati, F ;
Volonté, D ;
Engelman, JA ;
Scherer, PE ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (42) :30315-30321
[9]   Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities [J].
Galbiati, F ;
Engelman, JA ;
Volonte, D ;
Zhang, XL ;
Minetti, C ;
Li, MM ;
Hou, H ;
Kneitz, B ;
Edelmann, W ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (24) :21425-21433
[10]   Emerging themes in lipid rafts and caveolae [J].
Galbiati, F ;
Razani, B ;
Lisanti, MP .
CELL, 2001, 106 (04) :403-411